Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non‐small cell lung cancer patients

BACKGROUND: It is unclear whether the chemotherapy response improves after exposure to immunotherapy. Antiangiogenic agents have been shown to stimulate the immune system and cause synergistic effects that stimulate tumor shrinkage. We conducted a retrospective study to evaluate improvement of the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiono, Ayako, Kaira, Kyoichi, Mouri, Atsuto, Yamaguchi, Ou, Hashimoto, Kosuke, Uchida, Takahiro, Miura, Yu, Nishihara, Fuyumi, Murayama, Yoshitake, Kobayashi, Kunihiko, Kagamu, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449234/
https://www.ncbi.nlm.nih.gov/pubmed/30809973
http://dx.doi.org/10.1111/1759-7714.12998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449234/
https://www.ncbi.nlm.nih.gov/pubmed/30809973
http://dx.doi.org/10.1111/1759-7714.12998

Ejemplares similares